Peripheral Tumor Location Predicts a Favorable Prognosis in Patients with Resected Small Cell Lung Cancer

Table 1

Clinicopathological and treatment characteristics.

Characteristics	Total (n = 119)
Age
Median (years)	56 (35–77)
<65	95 (79.8%)
≥65	24 (20.2%)
Sex
Female	43 (36.1%)
Male	76 (63.9%)
Smoking
Never-smoker	43 (36.1%)
Current smoker	76 (63.9%)
Staging
IA	43 (36.1%)
IB	12 (10.1%)
IIA	4 (3.4%)
IIB	24 (20.2%)
IIIA	35 (29.4%)
IIIB	1 (0.8%)
Treatment
Adjuvant chemotherapy	102 (85.7%)
Neoadjuvant chemotherapy	28 (23.5%)
Postoperative mediastinal RT	8 (6.7%)
PCI	10 (8.4%)